Skip to main content
Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
9.37
-0.17 (-1.83%)
At close: Jun 5, 2025, 4:00 PM
9.34
-0.03 (-0.27%)
After-hours: Jun 5, 2025, 4:00 PM EDT

Cartesian Therapeutics Revenue

Cartesian Therapeutics had revenue of $1.10M in the quarter ending March 31, 2025, a decrease of -81.16%. This brings the company's revenue in the last twelve months to $34.17M, up 31.91% year-over-year. In the year 2024, Cartesian Therapeutics had annual revenue of $38.91M with 49.64% growth.

Revenue (ttm)
$34.17M
Revenue Growth
+31.91%
P/S Ratio
6.12
Revenue / Employee
$517,773
Employees
66
Market Cap
242.41M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202438.91M12.91M49.64%
Dec 31, 202326.00M-84.77M-76.53%
Dec 31, 2022110.78M25.70M30.21%
Dec 31, 202185.08M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

RNAC News

More News